Background Several significant issues on clinical trials reporting the effect of arginine-containing dental products have been addressed in systematic reviews and metaanalyses identifying the need for high-quality randomized clinical trials. A further methodological analysis of the given systematic reviews with meta-analysis on arginine products might provide information for future high-quality randomized clinical trials and current clinical practice.
INTRODUCTION
T he majority of the arginine-containing dental products are oral care commodities for caries prevention. Two systematic reviews with meta-analysis evaluating the evidence on arginine formulations 1, 2 have been reported in the literature. Although few, the clinical trials included in both reviews identified a significant anticaries effect of argininebased intervention when compared with that of control, especially for high-risk groups.
Among the included studies in both reviews, 6 clinical trials were common while the others were unique, suggesting an overlap of the included studies. Several significant issues on the reported clinical trials have been raised in both reviews, identifying the need for high-quality randomized clinical trials (RCTs). The clinical trials included in the reviews were sponsored by the respective product manufacturing companies. Therefore, the body of evidence was downgraded, as the outcome assessments of the arginine formulations may be biased. Moreover, there was a wide variation in the follow-up of the studies. Li et al 1 suggested a follow-up period of no less than 6 months for human caries clinical trials to observe the adverse effects (if any) of the use of arginine. Similarly, concerns were raised by Ástvaldsdóttir et al 2 on missing out the complications and side effectsrelated outcomes with the use of arginine-containing dental products. Future studies on arginine-containing dental products should address the shortcomings outlined by these systematic reviews.
A meta-epidemiologic review (meta-assessment approach) aims to examine systematic reviews or meta-analysis (metadata) to provide data for methodological analysis, thereby explaining unexplored characteristics of primary studies. 3 A further methodological analysis of the given systematic reviews with meta-analysis on arginine products may provide information for the conduct of high-quality RCTs in the future. Therefore, the objective of this communication was to perform a meta-epidemiologic assessment of meta-analysis reporting on anticaries effect of argininecontaining formulations. This brief communication is structured by providing a summary of the systematic reviews followed by a meta-epidemiologic review analysis.
METHODS

Search, Sources, and Strategy
Three databases (PubMed, SCOPUS, and Web of Science) were searched until June 15, 2018, using the search strategy: [(arginine) AND (caries) AND (systematic review OR meta-analysis)] with appropriate review filters for individual databases. The inclusion criteria were peer-reviewed published systematic reviews and meta-analysis on the anticaries effect of arginine-containing formulations. Figure 1 details the selection process (using Preferred Reporting Items for Systematic Reviews and Meta-Analyses phases for study inclusion) of systematic reviews and meta-analysis for this meta-epidemiologic review. From the 24 initially identified records, only 2 articles were finally included for the review analysis. 
Records identified -24
Records screened for title/abstract -12
Records excluded -1 of 3
Records included -2 of 3 Disagreements during the review were resolved by consensus or by consultation with the third reviewer. RCTs, quasi-RCTs, and human in situ RCTs were considered for inclusion. Studies with healthy human subjects with/without dental caries lesions were included when the anticaries effect of arginine formulations in any modality was assessed and compared with placebo and/or fluorides.
In the study by Ástvaldsdóttir et al., the PubMed, the Cochrane Library, Centre for Reviews and Dissemination, and EMBASE databases were searched until April 2014 with no language restrictions to identify articles using search terms with combinations structured using appropriate Boolean operators (AND/OR). Two reviewers performed the screening and inclusion of articles independently. It was predetermined that at least one reviewer should consider the study relevant for full-text review. Inclusion criteria were based on structured questions to identify the dental caries incidence and progression in clinical trials evaluating the anticaries effect of arginine-containing dental products. RCTs (including in situ studies) that have compared the anticaries effect of arginine in fluoridated dental products (toothpaste, mouthwash, or other fluoride-containing dental products) to fluoride (alone)-containing dental products on dental caries incidence or progression in children, adolescents, and adults were considered for review. The duration of the study for inclusion extended from $2 months to $24 months, depending on the outcome measures. Studies with split-mouth design were excluded.
Key Study Factor
In the study by Li et al., the objective of the review was to assess the in vivo anticaries effect of arginine-containing formulations compared with that of fluorides and/or placebo. The studies included were assessed for quality using the Cochrane risk of bias assessment tool. The reviewers assessed conflict of interest by reviewing the study author's disclosures and acknowledgments. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used to assess the quality of evidence.
In the study by Ástvaldsdóttir et al., the aim of the review was to evaluate the evidence on the use of oral care products containing arginine and its preventive potential against the development of new dental caries lesions and progression of existing lesions in children and adults. Two reviewers independently (disagreements resolved by consensus or a third reviewer consultation) assessed studies for relevance and risk of bias using protocol for assessment of randomized studies and the overall scientific evidence quality using GRADE classification based on data extraction from included studies.
Main Outcome Measure
In the study by Li et al., the primary outcome measure was coronal/root caries increment or proportion of subjects developing new carious lesion. The primary study measure for early enamel carious lesion was the extent/severity of newly developed lesions. In addition, the secondary outcome measures were any side effects of the use of arginine. Continuous outcomes in the included study were summarized as mean and standard deviation; whereas for dichotomous outcomes, risk ratio and 95% confidence interval were extracted. Meta-analysis was performed if the articles included had similarities in their problems/ population/patient-intervention-comparison-outcome-study type framework with low or moderate risk of bias.
In the study by Ástvaldsdóttir et al., dental caries incidence (subject to dentition) measured as dft/dfs/DMFT/DMFS was the primary outcome measure to discern primary and secondary (affected permanent teeth) caries prevention. In addition, the secondary outcome measure was enamel fluorescence values quantified using quantitative lightinduced fluorescence. Mean differences for the continuous outcome measures were calculated for meta-analysis using a random effects model for primary studies with insignificant clinical and statistical heterogeneity.
Main Results
In the study by Li et al., 10 studies (9 RCTs and 1 in situ study) were included for the systematic review, among which 7 studies were subjected to quantitative synthesis (meta-analysis). Most of the participants (as per studies included) were children or adolescents with assessment performed on their permanent teeth. Duration of included studies varied from 2 weeks to 24 months. One study evaluated the effect of CaviStat mint confection, whereas others evaluated 1.5% arginine with insoluble calcium compound and 1450 ppm fluoride (sodium monofluorophosphate)-a product by Colgate-Palmolive. The meta-analysis showed that the arginine formulations were significantly more effective than the controls in reducing dental caries incidence. No side effects were observed with arginine. GRADE network levels suggested the body of evidence being downgraded because of risk of bias and potential publication bias.
In the study by Ástvaldsdóttir et al., 7 studies were included for qualitative synthesis. Five of the 7 studies had participants who were children, of which 4 studies were at moderate risk of bias. The other 2 studies on adults were evaluated as high risk of bias. The studies with moderate risk of bias used arginine fluoride toothpaste as the experimental intervention and fluoride (only) toothpaste as control. Three of the 4 studies with moderate risk of bias were clinically, methodologically, and statistically nonheterogeneous and deemed fit for meta-analysis. Results of the meta-analysis favor the experimental intervention (weighted mean difference: 24.67, 95% confidence interval: 26.34 to 23.01) compared with the control, thereby demonstrating a greater remineralization effect in the experimental group. However, the effect of argininefluoride toothpaste was deemed as inconclusive because of conflict of interest. Ethical concerns were raised on the study design of several trials that directed the need for studies independent of financial interests with due inclusion of standard-care control therapeutic measures (fluorides).
Conclusion
Li et al. concluded, "Arginine in combination with calcium compound and fluoride provides a superior anticaries effect when compared to the matched fluoride formulations with downgraded level of evidence due to risk of bias and potential publication bias." Ástvaldsdóttir et al. concluded, "There is insufficient evidence to support the caries preventive effect of arginine in toothpastes."
Review Analysis
For meta-epidemiologic assessment, an observed evaluation is presented of bias assessment associated with effect size and precision estimates. To perform the analysis, we recomputed the common meta-analysis presented by both reviews (Figure 2) . The meta-analysis was performed using Stata C software v. 13 (StataCorp, LLC., Texas). The objective of reperforming the meta-analysis was to reverse the direction of effect size magnitude, indicating positive values (favoring intervention under investigation) as opposed to the negative direction as presented by published systematic reviews and meta-analysis. Simultaneously, the data on risk of bias assessment, effect size measure, dispersion of estimated precision, and follow-up period were summarized on a data sheet for further analysis using SPSS v. 24 (IBM SPSS Statistics Inc).
Meta-epidemiologic Review
Since a few noteworthy contributing results were identified with evaluations based on methodology, we recognize this article as a meta-epidemiologic review. The review highlights the observation of effect size measure and respective precision estimates, followed by its association with risk of bias assessment and correlation with follow-up period. The association of risk of bias assessment and effect size with precision estimates was qualitatively assessed, whereas the correlation of precision dispersion with effect size and follow-up period (individually) was quantitatively analyzed.
Risk of Bias Assessment, Effect Size, and Precision Estimates
The risk of bias assessment as highlighted by Li et al 1 evaluating the primary studies (included) was on arginine- containing formulations under random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases. The following sections were addressed as other biases-losses to follow-up , 20%, diagnosis reliability, balance of baseline characteristics, and free of contamination. The common meta-analysis presented in both reviews did not exhibit high risk of bias in the review assessment. In addition, Li et al 1 performed meta-analysis with other included studies. Compared with the other meta-analysis, the common metaanalysis ( Figure 2 ) in both reviews shows considerably larger magnitude of effect size estimates as weighted mean difference. In addition, the precision dispersion for these effect sizes was wider than the other meta-analysis by Li et al. 1 A retrospective examination of the primary studies included in the common meta-analysis with respect to the risk of bias assessment suggested that 2 studies 4,5 presented with unclear random sequence generation, allocation concealment, and other bias (free of contamination-strategies to avoid contamination between groups). One study 6 was reported with unclear random sequence generation and other bias (free of contamination). Based on the observation, it can be advocated that studies with larger magnitude of effect sizes might present with unclear random sequence generation and unclear allocation concealment representing the selection bias.
The observation is in concordance with a recently published meta-epidemiologic study on the impact of selection bias on effect size in RCTs of oral health interventions. 7 It was concluded by the review that effect size estimates are larger in trials with unknown sequence generation and unknown allocation concealment. Moreover, as observed in studies with arginine formulations, it appears that studies that have not reported strategies to avoid contamination between groups might also present with larger magnitude of effect size as observed in the current review. Therefore, it is suggested that future trials on arginine-containing formulations should limit the possibility of selection bias by appropriately conducting and reporting the sequence generation and allocation concealment. Furthermore, the strategies to avoid contamination should also be reported explicitly.
On evaluating the correlation between the effect size and precision dispersion of all the studies included in the metaanalysis as per Li et al., Spearman's rank order correlation demonstrated very strong positive significant correlation between the effect size and precision dispersion (r s 5 0.93, P 5 .003), which implied that with a large effect size magnitude, there is a possibility of wide dispersion ( Table 1) . Thus, reduction of selection bias might provide amenable effect size, which thereby controls the precision dispersion. The proposition is applicable to future clinical trials on arginine-based dental products and with exploration in due course of time to other oral health care interventions.
Follow-up Period and Estimated Precision Dispersion
While conducting the review, the authors identified that the magnitude of effect size was higher in studies with shorter follow-up. The observation led to further analysis on the correlation between follow-up time and the estimated precision dispersion using Spearman's rank-order correlation test. The nonparametric measure of correlation identified a significant strong negative correlation between follow-up time and dispersion of precision estimates (r s 5 20.79, P 5 .034) ( Table 1) . Thus, the shorter follow-up time of studies on oral care products containing arginine is related to a wide dispersion of precision estimates. Therefore, future clinical trials on oral care products containing arginine should have a longer follow-up period to show pragmatic treatment effect measures.
In summary, based on the suggestions highlighted in this brief communication, the meta-epidemiologic review on meta-analysis of oral care products containing arginine reveals insights on proper conduct of clinical trials. Considering these suggestions, future clinical trials on oral care products containing arginine should provide effect size measures that can identify the treatment effect precisely. In addition, considering the need for more non-industry-supported, well-designed, high-quality RCTs on oral care products containing arginine, it is of vital importance that the clinical trials contemplate factors in their methodology that provide amenable effect size measures when synthesized to evaluate evidence.
A major limitation of the meta-epidemiologic study is lack of reporting guidelines. Given the state, some metaepidemiologic studies need to resort to Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement for reporting the review analysis. Although a reporting guideline for meta-epidemiologic research was 
CONCLUSION
In summary, clinical trials on oral care products containing arginine have methodological shortcomings whereby selection bias and follow-up period influence the effect size magnitude and subsequent precision dispersion during evidence synthesis.
